Skip to main content
OpenTrials

Clinical trial condition

Post-ET Myelofibrosis

Explore clinical trials studying Post-ET Myelofibrosis. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Post-ET Myelofibrosis trial results

Recruiting

Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib

NCT05280509

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Gabrail Cancer Center Canton, Ohio, United States
  • University of Cincinnati (UC) Cincinnati, Ohio, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 19 locations
View Trial Details

Related conditions